The WACC of Gensight Biologics SA (SIGHT.PA) is 7.1%.
| Range | Selected | |
| Cost of equity | 6.20% - 8.90% | 7.55% |
| Tax rate | -% - -% | -% |
| Cost of debt | 5.90% - 7.00% | 6.45% |
| WACC | 6.1% - 8.2% | 7.1% |
| Category | Low | High |
| Long-term bond rate | 3.0% | 3.5% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.55 | 0.72 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.20% | 8.90% |
| Tax rate | -% | -% |
| Debt/Equity ratio | 0.65 | 0.65 |
| Cost of debt | 5.90% | 7.00% |
| After-tax WACC | 6.1% | 8.2% |
| Selected WACC | 7.1% | |